IGC Pharma (IGC) Short Interest Ratio & Short Volume → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free IGC Stock Alerts $0.49 -0.01 (-2.01%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort Interest IGC Pharma Short Interest DataCurrent Short Interest1,330,000 sharesPrevious Short Interest1,210,000 sharesChange Vs. Previous Month+9.92%Dollar Volume Sold Short$0.00Short Interest Ratio1.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares66,810,000 sharesPercentage of Shares Shorted1.99%Today's Trading Volume198,641 sharesAverage Trading Volume375,232 sharesToday's Volume Vs. Average53% Short Selling IGC Pharma ? Sign up to receive the latest short interest report for IGC Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIGC Short Interest Over TimeIGC Days to Cover Over TimeIGC Percentage of Float Shorted Over Time Ad InvestorPlaceWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details IGC Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,330,000 shares $0.00 +9.9%N/A1.3 $0.00 4/30/20241,210,000 shares $0.00 +57.5%N/A1.2 $0.00 4/15/2024768,100 shares $0.00 -18.2%N/A0.8 $0.00 3/31/2024938,800 shares $0.00 +10.6%N/A1.3 $0.00 3/15/2024848,500 shares $0.00 -6.8%N/A1.8 $0.00 2/29/2024910,700 shares $0.00 -1.7%N/A2.2 $0.00 Get the Latest News and Ratings for IGC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IGC Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024926,300 shares $0.00 -3.6%N/A2.9 $0.00 1/31/2024961,300 shares $0.00 +13.8%N/A3.7 $0.00 1/15/2024844,800 shares $0.00 -3.9%N/A2.9 $0.00 12/31/2023879,400 shares $0.00 -5.5%N/A3.5 $0.00 12/15/2023930,700 shares $0.00 -0.6%N/A3.9 $0.00 11/30/2023936,100 shares $0.00 +1.0%N/A4 $0.00 11/15/2023927,100 shares $0.00 -4.4%N/A3.6 $0.00 10/31/2023970,000 shares $0.00 +16.2%N/A3.9 $0.00 10/15/2023835,000 shares $0.00 +4.8%2.0%3.3 $0.00 9/30/2023796,900 shares $0.00 -10.1%1.9%3.8 $0.00 9/15/2023886,000 shares $387,447.80 +4.2%2.1%3.7 $0.44 8/31/2023850,600 shares $294,137.48 +7.0%2.1%4.1 $0.35 8/15/2023795,000 shares $0.00 -0.6%N/A4.8 $0.00 7/31/2023799,900 shares $0.00 -5.2%N/A4.7 $0.00 7/15/2023843,600 shares $0.00 -2.1%N/A5.4 $0.00 6/30/2023861,800 shares $0.00 -0.4%N/A5.7 $0.00 6/15/2023865,100 shares $0.00 -5.4%N/A8 $0.00 5/31/2023914,000 shares $0.00 +1.9%N/A8.2 $0.00 5/15/2023896,700 shares $0.00 -14.6%N/A8.8 $0.00 4/30/20231,050,000 shares $0.00 +12.2%2.4%9.8 $0.00 4/15/2023935,500 shares $0.00 +0.2%2.2%8 $0.00 3/31/2023933,500 shares $0.00 -1.1%2.2%7.6 $0.00 3/15/2023943,800 shares $0.00 +0.5%2.2%6 $0.00 2/28/2023939,100 shares $0.00 +5.4%2.2%5.8 $0.00 2/15/2023891,300 shares $0.00 +15.3%2.1%5.3 $0.00 1/31/2023773,200 shares $309,280.00 +0.3%1.8%4.4 $0.40 1/15/2023771,200 shares $0.00 -18.4%1.8%4.6 $0.00 12/30/2022945,100 shares $0.00 -2.8%2.2%5.7 $0.00 12/15/2022972,600 shares $0.00 -10.8%2.2%4.9 $0.00 11/30/20221,090,000 shares $0.00 -1.8%2.5%3.6 $0.00 11/15/20221,110,000 shares $0.00 +2.8%N/A3.8 $0.00 10/31/20221,080,000 shares $0.00 -1.8%N/A3.2 $0.00 10/15/20221,100,000 shares $0.00 +0.9%N/A3 $0.00 9/30/20221,090,000 shares $0.00 +0.9%N/A2.4 $0.00Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 9/15/20221,080,000 shares $0.00 +4.9%N/A2.7 $0.00 8/31/20221,030,000 shares $0.00 -3.7%N/A1.5 $0.00 8/15/20221,070,000 shares $0.00 -5.3%N/A1.5 $0.00 7/31/20221,130,000 shares $0.00 +5.6%N/A1.6 $0.00 7/15/20221,070,000 shares $0.00 No ChangeN/A1.5 $0.00 6/30/20221,070,000 shares $0.00 -32.7%N/A1.7 $0.00 6/15/20221,590,000 shares $0.00 +24.2%4.6%2.1 $0.00 5/31/20221,280,000 shares $0.00 +2.4%N/A2 $0.00 5/15/20221,250,000 shares $0.00 -4.6%N/A3.1 $0.00 4/30/20221,310,000 shares $0.00 No ChangeN/A3.5 $0.00 4/15/20221,310,000 shares $0.00 +11.0%N/A3.3 $0.00 3/31/20221,180,000 shares $1.12 million -8.5%N/A2.9 $0.95 3/15/20221,290,000 shares $0.00 -11.6%N/A3.9 $0.00 2/28/20221,460,000 shares $0.00 -12.1%N/A4.1 $0.00 2/15/20221,660,000 shares $0.00 -11.2%N/A3.3 $0.00 1/31/20221,870,000 shares $0.00 -1.6%N/A2.9 $0.00 1/15/20221,900,000 shares $0.00 -12.4%N/A2.1 $0.00 12/31/20212,170,000 shares $0.00 -10.7%N/A2.3 $0.00 12/15/20212,430,000 shares $0.00 +11.0%N/A2.5 $0.00 11/30/20212,190,000 shares $2.87 million +21.7%N/A2.1 $1.31 11/15/20211,800,000 shares $0.00 -5.3%N/A1.7 $0.00 10/29/20211,900,000 shares $2.66 million +10.5%N/A1.8 $1.40 10/15/20211,720,000 shares $0.00 +24.6%N/A1.5 $0.00 9/30/20211,380,000 shares $0.00 -52.1%N/A0.2 $0.00 9/15/20212,880,000 shares $0.00 +12.9%N/A0.4 $0.00 8/31/20212,550,000 shares $0.00 -4.5%5.9%0.3 $0.00 8/13/20212,670,000 shares $0.00 -16.0%6.2%0.3 $0.00 7/30/20213,180,000 shares $0.00 +18.7%7.6%0.4 $0.00 7/15/20212,680,000 shares $0.00 -13.6%6.4%0.4 $0.00 6/30/20213,100,000 shares $0.00 -6.9%7.4%1.3 $0.00 6/15/20213,330,000 shares $0.00 +34.8%8.0%2.1 $0.00 5/28/20212,470,000 shares $0.00 +9.8%6.5%1.4 $0.00 5/14/20212,250,000 shares $0.00 +4.7%5.9%1.2 $0.00 4/30/20212,150,000 shares $0.00 -5.7%5.5%0.6 $0.00 4/15/20212,280,000 shares $3.44 million -10.6%5.8%0.5 $1.51 3/31/20212,550,000 shares $4.18 million -18.8%6.5%0.5 $1.64 3/15/20213,140,000 shares $5.09 million +14.6%8.0%0.6 $1.62 2/26/20212,740,000 shares $4.71 million +14.2%7.1%0.5 $1.72 2/12/20212,400,000 shares $4.13 million +27.0%6.2%0.4 $1.72 1/29/20211,890,000 shares $3.65 million +11.8%5.4%0.4 $1.93 1/15/20211,690,000 shares $3.80 million -32.7%4.8%0.5 $2.25 12/31/20202,510,000 shares $4.22 million +4.2%6.9%0.7 $1.68 12/15/20202,410,000 shares $3.98 million +42.6%6.6%0.7 $1.65 11/30/20201,690,000 shares $3.21 million +4.3%4.8%0.5 $1.90 11/15/20201,620,000 shares $2.06 million -18.2%4.7%0.5 $1.27 10/30/20201,980,000 shares $2.26 million -17.5%5.8%0.1 $1.14 10/15/20202,400,000 shares $3.07 million +23.1%7.0%0.2 $1.28 9/30/20201,950,000 shares $2.03 million -11.4%5.7%0.2 $1.04 9/15/20202,200,000 shares $2.27 million -11.3%6.4%0.2 $1.03 8/31/20202,480,000 shares $2.80 million -42.7%7.3%0.2 $1.13Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 8/14/20204,330,000 shares $4.94 million +126.7%12.7%0.4 $1.14 7/31/20201,910,000 shares $3.23 million +2.7%5.6%1.5 $1.69 7/15/20201,860,000 shares $1.13 million -1.6%5.4%1.9 $0.61 6/30/20201,890,000 shares $1.04 million -3.1%5.6%1.9 $0.55 6/15/20201,950,000 shares $1.09 million -1.5%5.8%2 $0.56 5/29/20201,980,000 shares $1.11 million -0.5%5.9%2.1 $0.56 5/15/20201,990,000 shares $1.17 million +4.2%5.9%2.3 $0.59 4/30/20201,910,000 shares $1.17 million -1.6%5.7%2.8 $0.61 4/15/20201,940,000 shares $970,000.00 -3.5%5.7%4.2 $0.50 3/31/20202,010,000 shares $1.01 million -0.4%5.9%4 $0.50 3/13/20202,017,300 shares $907,785.00 +0.9%6.0%5.5 $0.45 2/28/20202,000,000 shares $680,000.00 -7.0%5.9%5.4 $0.34 2/14/20202,150,000 shares $924,500.00 +4.4%6.3%5.5 $0.43 1/31/20202,060,000 shares $1.01 million +3.0%6.0%5.3 $0.49 1/15/20202,000,000 shares $1.18 million +1.5%5.9%4.9 $0.59 12/31/20191,970,000 shares $1.30 million -2.5%5.8%5.5 $0.66 8/15/2019977,000 shares $1.03 million -14.9%2.8%0.7 $1.05 IGC Short Interest - Frequently Asked Questions What is IGC Pharma's current short interest? Short interest is the volume of IGC Pharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 1,330,000 shares of IGC short. Learn More on IGC Pharma's current short interest. What is a good short interest ratio for IGC Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IGC shares currently have a short interest ratio of 1.0. Learn More on IGC Pharma's short interest ratio. Is IGC Pharma's short interest increasing or decreasing? IGC Pharma saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,330,000 shares, an increase of 9.9% from the previous total of 1,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does IGC Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to IGC Pharma: ProMIS Neurosciences, Inc. (0.05%), Sensei Biotherapeutics, Inc. (0.49%), RenovoRx, Inc. (0.22%), Marker Therapeutics, Inc. (0.78%), Reviva Pharmaceuticals Holdings, Inc. (6.38%), Spruce Biosciences, Inc. (0.30%), Viracta Therapeutics, Inc. (2.42%), JanOne Inc. (2.92%), Helix BioPharma Corp. (0.00%), ImmunoPrecise Antibodies Ltd. (0.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short IGC Pharma stock? Short selling IGC is an investing strategy that aims to generate trading profit from IGC Pharma as its price is falling. IGC shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IGC Pharma? A short squeeze for IGC Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IGC, which in turn drives the price of the stock up even further. How often is IGC Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IGC, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ProMIS Neurosciences Short Squeeze Sensei Biotherapeutics Short Squeeze RenovoRx Short Squeeze Marker Therapeutics Short Squeeze Reviva Pharmaceuticals Short Squeeze Spruce Biosciences Short Squeeze Viracta Therapeutics Short Squeeze JanOne Short Squeeze Helix BioPharma Short Squeeze ImmunoPrecise Antibodies Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:IGC) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss Ratings“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.